• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非典型子宫内膜增生女性并发子宫内膜癌:患者特征的预测价值是什么?

Concurrent Endometrial Cancer in Women with Atypical Endometrial Hyperplasia: What Is the Predictive Value of Patient Characteristics?

作者信息

Giannella Luca, Piva Francesco, Delli Carpini Giovanni, Di Giuseppe Jacopo, Grelloni Camilla, Giulietti Matteo, Sopracordevole Francesco, Giorda Giorgio, Del Fabro Anna, Clemente Nicolò, Gardella Barbara, Bogani Giorgio, Brasile Orsola, Martinello Ruby, Caretto Marta, Ghelardi Alessandro, Albanesi Gianluca, Stevenazzi Guido, Venturini Paolo, Papiccio Maria, Cannì Marco, Barbero Maggiorino, Fambrini Massimiliano, Maggi Veronica, Uccella Stefano, Spinillo Arsenio, Raspagliesi Francesco, Greco Pantaleo, Simoncini Tommaso, Petraglia Felice, Ciavattini Andrea

机构信息

Woman's Health Sciences Department, Gynecologic Section, Polytechnic University of Marche, 60123 Ancona, Italy.

Department of Specialistic Clinical and Odontostomatological Sciences, Polytechnic University of Marche, 60131 Ancona, Italy.

出版信息

Cancers (Basel). 2023 Dec 29;16(1):172. doi: 10.3390/cancers16010172.

DOI:10.3390/cancers16010172
PMID:
38201599
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10778118/
Abstract

BACKGROUND

The rate of concurrent endometrial cancer (EC) in atypical endometrial hyperplasia (AEH) can be as high as 40%. Some patient characteristics showed associations with this occurrence. However, their real predictive power with related validation has yet to be discovered. The present study aimed to assess the performance of various models based on patient characteristics in predicting EC in women with AEH.

METHODS

This is a retrospective multi-institutional study including women with AEH undergoing definitive surgery. The women were divided according to the final histology (EC vs. no-EC). The available cases were divided into a training and validation set. Using k-fold cross-validation, we built many predictive models, including regressions and artificial neural networks (ANN).

RESULTS

A total of 193/629 women (30.7%) showed EC at hysterectomy. A total of 26/193 (13.4%) women showed high-risk EC. Regression and ANN models showed a prediction performance with a mean area under the curve of 0.65 and 0.75 on the validation set, respectively. Among the best prediction models, the most recurrent patient characteristics were age, body mass index, Lynch syndrome, diabetes, and previous breast cancer. None of these independent variables showed associations with high-risk diseases in women with EC.

CONCLUSIONS

Patient characteristics did not show satisfactory performance in predicting EC in AEH. Risk stratification in AEH based mainly on patient characteristics may be clinically unsuitable.

摘要

背景

非典型子宫内膜增生(AEH)患者并发子宫内膜癌(EC)的发生率可高达40%。一些患者特征与这种情况相关。然而,它们真正的预测能力以及相关验证尚未被发现。本研究旨在评估基于患者特征的各种模型在预测AEH女性患者发生EC方面的性能。

方法

这是一项回顾性多机构研究,纳入了接受确定性手术的AEH女性患者。根据最终组织学结果(EC与非EC)对这些女性进行分组。将可用病例分为训练集和验证集。使用k折交叉验证,我们构建了许多预测模型,包括回归模型和人工神经网络(ANN)。

结果

共有193/629名女性(30.7%)在子宫切除术中被诊断为EC。共有26/193名女性(13.4%)患有高危EC。回归模型和ANN模型在验证集上的预测性能分别显示曲线下平均面积为0.65和0.75。在最佳预测模型中,最常出现的患者特征是年龄、体重指数、林奇综合征、糖尿病和既往乳腺癌。这些自变量均未显示与EC女性患者的高危疾病相关。

结论

患者特征在预测AEH患者发生EC方面表现并不理想。主要基于患者特征对AEH进行风险分层在临床上可能并不合适。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc23/10778118/e49f4e7b3158/cancers-16-00172-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc23/10778118/e49f4e7b3158/cancers-16-00172-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc23/10778118/e49f4e7b3158/cancers-16-00172-g001.jpg

相似文献

1
Concurrent Endometrial Cancer in Women with Atypical Endometrial Hyperplasia: What Is the Predictive Value of Patient Characteristics?非典型子宫内膜增生女性并发子宫内膜癌:患者特征的预测价值是什么?
Cancers (Basel). 2023 Dec 29;16(1):172. doi: 10.3390/cancers16010172.
2
Atypical Endometrial Hyperplasia and Unexpected Cancers at Final Histology: A Study on Endometrial Sampling Methods and Risk Factors.非典型子宫内膜增生与最终组织学检查时意外发现的癌症:一项关于子宫内膜取样方法和危险因素的研究
Diagnostics (Basel). 2020 Jul 13;10(7):474. doi: 10.3390/diagnostics10070474.
3
Risk of occult atypical hyperplasia or cancer in women with nonatypical endometrial hyperplasia.非非典型子宫内膜增生女性发生隐匿性非典型增生或癌症的风险。
J Obstet Gynaecol Res. 2020 Dec;46(12):2505-2510. doi: 10.1111/jog.14474. Epub 2020 Sep 17.
4
Clinical, Sonographic, and Hysteroscopic Features of Endometrial Carcinoma Diagnosed after Hysterectomy in Patients with a Preoperative Diagnosis of Atypical Hyperplasia: A Single-Center Retrospective Study.术前诊断为非典型增生的患者子宫切除术后诊断出的子宫内膜癌的临床、超声及宫腔镜特征:一项单中心回顾性研究
Diagnostics (Basel). 2022 Dec 2;12(12):3029. doi: 10.3390/diagnostics12123029.
5
Endometrial Cancer Incidence in Patients With Atypical Endometrial Hyperplasia According to Mode of Management.根据治疗方式分析非典型子宫内膜增生患者的子宫内膜癌发病率
Cancer Diagn Progn. 2022 Sep 3;2(5):564-568. doi: 10.21873/cdp.10143. eCollection 2022 Sep-Oct.
6
Should we prioritise proper surgical staging for patients with Atypical endometrial hyperplasia (AEH)? Experience from a single-institution tertiary care oncology centre.对于患有非典型子宫内膜增生(AEH)的患者,我们是否应优先进行适当的手术分期?一家三级肿瘤专科医院的经验。
Eur J Obstet Gynecol Reprod Biol. 2024 Dec;303:1-8. doi: 10.1016/j.ejogrb.2024.09.044. Epub 2024 Oct 3.
7
Hysteroscopic inspection and total curettage are insufficient for discriminating endometrial cancer from atypical endometrial hyperplasia.宫腔镜检查和全面刮宫术不足以区分子宫内膜癌和非典型子宫内膜增生。
Tohoku J Exp Med. 2012 Dec;228(4):365-70. doi: 10.1620/tjem.228.365.
8
Menopausal Status Combined with Serum CA125 Level Significantly Predicted Concurrent Endometrial Cancer in Women Diagnosed with Atypical Endometrial Hyperplasia before Surgery .绝经状态联合血清CA125水平可显著预测术前诊断为非典型子宫内膜增生的女性并发子宫内膜癌的情况。
Diagnostics (Basel). 2021 Dec 21;12(1):6. doi: 10.3390/diagnostics12010006.
9
Frozen section pathology at time of hysterectomy accurately predicts endometrial cancer in patients with preoperative diagnosis of atypical endometrial hyperplasia.在子宫切除术前诊断为不典型子宫内膜增生的患者中,手术时的冰冻切片病理检查可准确预测子宫内膜癌。
Gynecol Oncol. 2012 Jun;125(3):536-40. doi: 10.1016/j.ygyno.2012.02.011. Epub 2012 Feb 21.
10
End-to-end deep learning method for predicting hormonal treatment response in women with atypical endometrial hyperplasia or endometrial cancer.用于预测非典型子宫内膜增生或子宫内膜癌女性激素治疗反应的端到端深度学习方法。
J Med Imaging (Bellingham). 2024 Jan;11(1):017502. doi: 10.1117/1.JMI.11.1.017502. Epub 2024 Feb 15.

引用本文的文献

1
Human Epididymis Protein 4 Predicted Concurrent Intermediate-high-risk Endometrial Cancer and Eligibility of Fertility-sparing Treatment for Patients Diagnosed with Endometrial Atypical Hyperplasia Before Surgery.人附睾蛋白4预测同时存在的中高危子宫内膜癌及术前诊断为子宫内膜非典型增生患者保留生育功能治疗的适用性。
Int J Med Sci. 2025 Jul 11;22(13):3292-3303. doi: 10.7150/ijms.115170. eCollection 2025.
2
SCENE: Signature Collection for Endometrial Cancer Prognosis.场景:子宫内膜癌预后的签名收集
J Cell Mol Med. 2025 Aug;29(15):e70762. doi: 10.1111/jcmm.70762.
3
Tissue-Based Metabolomic Profiling of Endometrial Cancer and Hyperplasia.

本文引用的文献

1
Receiver operating characteristic curve: overview and practical use for clinicians.受试者工作特征曲线:概述与临床医师的实际应用
Korean J Anesthesiol. 2022 Feb;75(1):25-36. doi: 10.4097/kja.21209. Epub 2022 Jan 18.
2
The significance of plasma D-dimer level in predicting high risk factors of endometrial cancer.血浆D-二聚体水平在预测子宫内膜癌高危因素中的意义。
Transl Cancer Res. 2020 Dec;9(12):7688-7696. doi: 10.21037/tcr.2020.04.22.
3
Endometrial hyperplasia as a risk factor of endometrial cancer.子宫内膜增生作为子宫内膜癌的一个风险因素。
子宫内膜癌和子宫内膜增生的组织代谢组学分析
Metabolites. 2025 Jul 5;15(7):458. doi: 10.3390/metabo15070458.
4
Preoperative predictors of endometrial carcinoma in patients undergoing hysterectomy for endometrial intraepithelial neoplasia.接受子宫内膜上皮内瘤变子宫切除术患者子宫内膜癌的术前预测因素。
BMC Cancer. 2025 May 16;25(1):883. doi: 10.1186/s12885-025-14312-8.
5
Artificial Intelligence in Gynecological Oncology from Diagnosis to Surgery.从诊断到手术的妇科肿瘤学中的人工智能
Cancers (Basel). 2025 Mar 21;17(7):1060. doi: 10.3390/cancers17071060.
6
Preoperative predictors of concurrent endometrial carcinoma in patients with endometrial intraepithelial neoplasia: the role of HALP score and other inflammatory markers.子宫内膜上皮内瘤变患者并发子宫内膜癌的术前预测指标:HALP评分及其他炎症标志物的作用
J Turk Ger Gynecol Assoc. 2025 Mar 12;26(1):34-40. doi: 10.4274/jtgga.galenos.2025.2024-12-5.
7
Association of body mass index with pathologic agreement of preoperative and postoperative tumor grade in endometrial cancer.子宫内膜癌患者体重指数与术前术后肿瘤分级病理一致性的关联
Arch Gynecol Obstet. 2025 Feb;311(2):459-465. doi: 10.1007/s00404-024-07829-z. Epub 2024 Nov 15.
8
Nomogram using human epididymis protein 4 predicted concurrent endometrial cancer from endometrial atypical hyperplasia before surgery.利用人附睾蛋白4的列线图在术前预测子宫内膜非典型增生并发子宫内膜癌。
Front Oncol. 2024 Sep 6;14:1442127. doi: 10.3389/fonc.2024.1442127. eCollection 2024.
9
Atypical Endometrial Hyperplasia and Concurrent Cancer: A Comprehensive Overview on a Challenging Clinical Condition.非典型子宫内膜增生与并发癌症:对一种具有挑战性临床状况的全面概述
Cancers (Basel). 2024 Feb 24;16(5):914. doi: 10.3390/cancers16050914.
Arch Gynecol Obstet. 2022 Aug;306(2):407-421. doi: 10.1007/s00404-021-06380-5. Epub 2022 Jan 10.
4
Clinical features of ProMisE groups identify different phenotypes of patients with endometrial cancer.ProMisE 分组的临床特征可识别出子宫内膜癌患者的不同表型。
Arch Gynecol Obstet. 2021 Jun;303(6):1393-1400. doi: 10.1007/s00404-021-06028-4. Epub 2021 Mar 23.
5
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.ESGO/ESTRO/ESP 子宫内膜癌管理指南。
Int J Gynecol Cancer. 2021 Jan;31(1):12-39. doi: 10.1136/ijgc-2020-002230. Epub 2020 Dec 18.
6
Atypical Endometrial Hyperplasia and Unexpected Cancers at Final Histology: A Study on Endometrial Sampling Methods and Risk Factors.非典型子宫内膜增生与最终组织学检查时意外发现的癌症:一项关于子宫内膜取样方法和危险因素的研究
Diagnostics (Basel). 2020 Jul 13;10(7):474. doi: 10.3390/diagnostics10070474.
7
Calculating the sample size required for developing a clinical prediction model.计算开发临床预测模型所需的样本量。
BMJ. 2020 Mar 18;368:m441. doi: 10.1136/bmj.m441.
8
Mutational profile of endometrial hyperplasia and risk of progression to endometrioid adenocarcinoma.子宫内膜增生的突变特征与子宫内膜样腺癌进展的风险。
Cancer. 2020 Jun 15;126(12):2775-2783. doi: 10.1002/cncr.32822. Epub 2020 Mar 18.
9
A New Risk Index Combining d-Dimer, Fibrinogen, HE4, and CA199 Differentiates Suspecting Endometrial Cancer From Patients With Abnormal Vaginal Bleeding or Discharge.一种联合 d-二聚体、纤维蛋白原、HE4 和 CA199 的新型风险指数可区分疑似子宫内膜癌患者与阴道异常出血或排液患者。
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033819901117. doi: 10.1177/1533033819901117.
10
Preoperative predictors of endometrial cancer at time of hysterectomy for endometrial intraepithelial neoplasia or complex atypical hyperplasia.经阴道子宫切除术前子宫内膜上皮内瘤变或复杂不典型增生患者的子宫内膜癌术前预测指标。
Am J Obstet Gynecol. 2020 Jan;222(1):60.e1-60.e7. doi: 10.1016/j.ajog.2019.08.002. Epub 2019 Aug 8.